NASDAQ:MSON - Misonix Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$16.38 -0.12 (-0.73 %)
(As of 12/12/2018 03:21 AM ET)
Previous Close$16.50
Today's Range$16.02 - $16.51
52-Week Range$8.25 - $21.43
Volume10,400 shs
Average Volume17,241 shs
Market Capitalization$157.30 million
P/E RatioN/A
Dividend YieldN/A
Beta0.39
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States, the Americas, Europe, Middle East, Asia Pacific, Africa, and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.

Receive MSON News and Ratings via Email

Sign-up to receive the latest news and ratings for MSON and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Laboratory apparatus & furniture
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:MSON
Previous Symbol
CUSIPN/A
Phone631-694-9555

Debt

Debt-to-Equity RatioN/A
Current Ratio4.61
Quick Ratio3.49

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$36.68 million
Price / Sales4.26
Cash FlowN/A
Price / Cash FlowN/A
Book Value$2.59 per share
Price / Book6.32

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-7,610,000.00
Net Margins-23.24%
Return on Equity-14.05%
Return on Assets-11.75%

Miscellaneous

Employees118
Outstanding Shares9,530,000
Market Cap$157.30 million
OptionableNot Optionable

Misonix (NASDAQ:MSON) Frequently Asked Questions

What is Misonix's stock symbol?

Misonix trades on the NASDAQ under the ticker symbol "MSON."

How were Misonix's earnings last quarter?

Misonix, Inc. (NASDAQ:MSON) announced its quarterly earnings results on Thursday, November, 8th. The medical equipment provider reported ($0.29) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.20) by $0.09. The medical equipment provider earned $9.36 million during the quarter. Misonix had a negative net margin of 23.24% and a negative return on equity of 14.05%. View Misonix's Earnings History.

When is Misonix's next earnings date?

Misonix is scheduled to release their next quarterly earnings announcement on Tuesday, February 5th 2019. View Earnings Estimates for Misonix.

What price target have analysts set for MSON?

2 brokerages have issued 12-month price targets for Misonix's stock. Their forecasts range from $24.00 to $28.00. On average, they expect Misonix's share price to reach $26.00 in the next twelve months. This suggests a possible upside of 58.7% from the stock's current price. View Analyst Price Targets for Misonix.

What is the consensus analysts' recommendation for Misonix?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Misonix in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Misonix.

Has Misonix been receiving favorable news coverage?

Headlines about MSON stock have been trending positive recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Misonix earned a news sentiment score of 2.6 on InfoTrie's scale. They also assigned news stories about the medical equipment provider a news buzz of 3.0 out of 10, indicating that recent news coverage is unlikely to have an effect on the stock's share price in the immediate future.

Who are some of Misonix's key competitors?

Who are Misonix's key executives?

Misonix's management team includes the folowing people:
  • Mr. Stavros George Vizirgianakis, Pres, CEO & Director (Age 48)
  • Mr. Joseph P. Dwyer, CFO, Treasurer & Sec. (Age 62)
  • Mr. Robert Scott Ludecker, Sr. VP of Global Sales & Marketing (Age 51)
  • Mr. Dan Voic, VP of R&D & Engineering (Age 56)
  • Mr. Christopher H. Wright, VP of Domestic Sales (Age 43)

Who are Misonix's major shareholders?

Misonix's stock is owned by many different of retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (3.93%), Renaissance Technologies LLC (2.46%), Vanguard Group Inc. (2.24%), Bridgeway Capital Management Inc. (0.72%), Ingalls & Snyder LLC (0.65%) and EAM Investors LLC (0.47%). Company insiders that own Misonix stock include Christopher H Wright, Joseph J Brennan, Joseph P Dwyer, Patrick A Mcbrayer and Thomas M Patton. View Institutional Ownership Trends for Misonix.

Which institutional investors are selling Misonix stock?

MSON stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP. Company insiders that have sold Misonix company stock in the last year include Christopher H Wright and Joseph J Brennan. View Insider Buying and Selling for Misonix.

Which institutional investors are buying Misonix stock?

MSON stock was purchased by a variety of institutional investors in the last quarter, including Ingalls & Snyder LLC, EAM Investors LLC, Nordea Investment Management AB, ClariVest Asset Management LLC, Vanguard Group Inc., Renaissance Technologies LLC, Manatuck Hill Partners LLC and Bridgeway Capital Management Inc.. Company insiders that have bought Misonix stock in the last two years include Joseph P Dwyer, Patrick A Mcbrayer and Thomas M Patton. View Insider Buying and Selling for Misonix.

How do I buy shares of Misonix?

Shares of MSON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Misonix's stock price today?

One share of MSON stock can currently be purchased for approximately $16.38.

How big of a company is Misonix?

Misonix has a market capitalization of $157.30 million and generates $36.68 million in revenue each year. Misonix employs 118 workers across the globe.

What is Misonix's official website?

The official website for Misonix is http://www.misonix.com.

How can I contact Misonix?

Misonix's mailing address is 1938 NEW HIGHWAY, FARMINGDALE NY, 11735. The medical equipment provider can be reached via phone at 631-694-9555.


MarketBeat Community Rating for Misonix (NASDAQ MSON)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  66 (Vote Outperform)
Underperform Votes:  73 (Vote Underperform)
Total Votes:  139
MarketBeat's community ratings are surveys of what our community members think about Misonix and other stocks. Vote "Outperform" if you believe MSON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MSON will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/12/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel